X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc.

NNASDAQ:XFOR
2.83
USD
-0.29
(-9.29%)
-0.66EPS
292.62MMarket Cap
Mar 23Next Earn

Latest Stock Split

Apr 28, 2025

1:30

For every 30 shares held, investors received 1. The price per share adjusted from $0.19 to $5.70.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Apr 28, 2025
    Before$0.19
    Split ratio1:30
    After$5.70
    Reverse
  2. Mar 14, 2019
    Before—
    Split ratio1:6
    After—
    Reverse

About X4 Pharmaceuticals, Inc. stock splits

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) operates in the Biotechnology industry.

X4 Pharmaceuticals, Inc. company overview

When did X4 Pharmaceuticals, Inc. stock split?

X4 Pharmaceuticals, Inc.'s most recent stock split was on April 28, 2025. It was a 1-for-30 reverse split, so shareholders received 1 share for every 30 they held.

What is X4 Pharmaceuticals, Inc.'s stock split history?

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) has split its stock 2 times: a 1-for-6 reverse split on March 14, 2019 and a 1-for-30 reverse split on April 28, 2025.

How many times has X4 Pharmaceuticals, Inc. stock split?

X4 Pharmaceuticals, Inc. has split its stock 2 times. This history records 2 reverse splits between March 14, 2019 and April 28, 2025.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In X4 Pharmaceuticals, Inc.'s 1-for-30 reverse split on April 28, 2025, every 30 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will X4 Pharmaceuticals, Inc. split its stock again?

X4 Pharmaceuticals, Inc. has not announced a new split in our records. Its most recent split was on April 28, 2025, 1 year ago. Companies announce splits in advance, and any new NASDAQ:XFOR split will appear on this page.